Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

39.40
Delayed Data
As of Feb 23
 +0.95 / +2.47%
Today’s Change
24.65
Today|||52-Week Range
50.05
-1.13%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close38.45
Today’s open38.55
Day’s range38.15 - 39.70
Volume291,143
Average volume (3 months)547,072
Market cap$2.0B
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+528.57%
Earnings growth (this year)-38.42%
Earnings growth (next 5 years)+27.00%
Revenue growth (last year)+48.87%
P/E ratio35.8
Price/Sales6.07
Price/Book10.27

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...+0.16+1.06%
PRTAProthena Corporation...+0.96+2.85%
IRWDIronwood Pharmaceuti...-0.15-1.01%
HZNPHorizon Pharma PLC+0.14+1.00%
Data as of 4:00pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)$0.28
Annual revenue (last year)$215.0M
Annual profit (last year)$91.2M
Net profit margin42.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
Jack A. Khattar
Chief Financial Officer &
Vice President
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts